Inhibition of an apical cAMP/cGMP transporter(MRP4)in the gut induces diarrhea
Inhibition of an apical cAMP/cGMP transporter(MRP4)in the gut induces diarrhea
批准号:
8622190
负责人:
Anjaparavanda P Naren
金额:
$34.66万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-01-01 至 2018-03-31
关键词:
Abdominal PainAddressAffectApicalApplications GrantsAttentionAttenuatedCell membraneCellsChloride ChannelsChloride IonChloridesChronic DiseaseColitisColonCoupledCouplesCouplingCrohn&aposs diseaseCyclic AMPCyclic GMPCystic Fibrosis Transmembrane Conductance RegulatorDiarrheaDiseaseDistal part of ileumEpithelialEpithelial CellsEuropeFluids and SecretionsFundingGastrointestinal tract structureGenerationsGoalsHealthcareHigh PrevalenceHumanIn VitroIndividualInflammationInflammatory Bowel DiseasesKnockout MiceMacromolecular ComplexesMethodsModelingMucous MembraneNitric OxideNorth AmericaP-GlycoproteinsPDZ proteinPathway interactionsPharmaceutical PreparationsPhenotypePredispositionProcessProductionProteinsReportingResearchResourcesScaffolding ProteinSignal TransductionSodium Dextran SulfateSusceptibility GeneSymptomsTestingTherapeutic InterventionTissuesUlcerative ColitisUnited Statesapical membraneclinically relevantdisease phenotypegastrointestinal epitheliumhuman NOS2A proteinmolecular assembly/self assemblynoveloverexpressionprotein protein interactionpublic health relevancesodium-hydrogen exchanger regulatory factor
中文摘要
描述(由申请人提供):这项持续支持的申请将重点研究囊性纤维化跨膜传导调节剂(CFTR)、多药耐药蛋白4 (MRP4)和诱导型一氧化氮合酶(iNOS)之间的蛋白质-蛋白质相互作用如何促进溃疡性结肠炎(UC)中观察到的腹泻症状。我们的统一假设是,CFTR、NHERF2、MRP4和iNOS在UC肠道上皮质膜处或附近形成一个大分子复合物,该大分子复合物是UC腹泻致病过程所必需的。具体来说,我们提出UC中iNOS在肠道上皮质膜处过度表达,导致持续高水平的一氧化氮(NO)产生,从而触发NO-cGMP途径并产生区隔化的cGMP。由于iNOS在质膜上或质膜附近与CFTR、NHERF2和MRP4形成大分子复合物,这种no依赖性区隔化的cGMP触发CFTR氯通道的过度激活,从而导致腹泻表型。大分子复合物的破坏将取消inos依赖性cGMP生成和CFTR Cl-通道功能的功能耦合。本建议的具体目标是:验证iNOS在uc影响的人肠道上皮中过表达的假设,并检测其是否与CFTR和MRP4偶联并上调CFTR Cl-通道功能。为了验证iNOS、CFTR和MRP4在肠上皮细胞质膜处或附近形成大分子复合物,并且该大分子复合物是UC中观察到的腹泻的致病过程所必需的假设。所提出的研究不仅有助于我们更好地理解UC常见腹泻症状的机制,而且可能为该疾病的治疗干预提供新的靶点和方法。因此,本申请中提出的研究将对许多UC患者以及某些形式的分泌性腹泻患者具有临床意义。
英文摘要
DESCRIPTION (provided by applicant): This application for continued support will focus on studying how protein-protein interactions among the cystic fibrosis transmembrane conductance regulator (CFTR), multidrug resistance protein 4 (MRP4) and inducible nitric oxide synthase (iNOS) contribute to the diarrheal symptom observed in Ulcerative Colitis (UC). Our unifying hypothesis is that CFTR, NHERF2, MRP4 and iNOS form a macromolecular complex at or near the plasma membrane in gut epithelial in UC and this macromolecular complex is required for the pathogenic process of diarrhea observed in UC. Specifically, we proposed that iNOS is overexpressed at the plasma membrane of gut epithelia in UC, resulting in the production of sustained high level of nitric oxide (NO) which triggers NO-cGMP pathway and generates compartmentalized cGMP. Since iNOS forms a macromolecular complex with CFTR, NHERF2 and MRP4 at or near the plasma membrane, this NO-dependent compartmentalized cGMP triggers the hyperactivation of CFTR chloride channels and thus causes diarrhea phenotype. Disruption of the macromolecular complex will abolish the functional coupling of iNOS-dependent cGMP generation and CFTR Cl- channel function. The specific aims of this proposal are: Specific Aim 1. To test the hypothesis that iNOS is overexpressed in UC-affected human gut epithelia and to test whether it is coupled to CFTR and MRP4 and upregulates CFTR Cl- channel function Specific Aim 2. To test the hypothesis that iNOS, CFTR, and MRP4 form a macromolecular complex at or near the plasma membrane of gut epithelial cells and that this macromolecular complex is required for the pathogenic process of diarrhea observed in UC. The proposed studies will not only help us better understand the mechanisms underlying the diarrhea symptom commonly observed in UC, but probably provide novel targets and methods for therapeutic interventions of the disease. Therefore, the studies proposed in this application will have clinical relevance for many individuals suffering from UC and also for those suffering from certain forms of secretory diarrheas.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigating of the Mechanisms of Action of CFTR Correctors in RescuingDelta F508-CFTR
-
批准号:10406127
-
项目类别:
-
资助金额:$44.03万
-
财政年份:2020
-
负责人:Anjaparavanda P Naren
-
依托单位:
Investigating of the Mechanisms of Action of CFTR Correctors in RescuingDelta F508-CFTR
-
批准号:10454293
-
项目类别:
-
资助金额:$42.37万
-
财政年份:2020
-
负责人:Anjaparavanda P Naren
-
依托单位:
Investigating of the Mechanisms of Action of CFTR Correctors in RescuingDelta F508-CFTR
-
批准号:10656430
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2020
-
负责人:Anjaparavanda P Naren
-
依托单位:
Personalized Model System Core
-
批准号:10249242
-
项目类别:
-
资助金额:$22.63万
-
财政年份:2018
-
负责人:Anjaparavanda P Naren
-
依托单位:
Administrative Core
-
批准号:10477250
-
项目类别:
-
资助金额:$19.87万
-
财政年份:2018
-
负责人:Anjaparavanda P Naren
-
依托单位:
Administrative Core
-
批准号:10249240
-
项目类别:
-
资助金额:$19.89万
-
财政年份:2018
-
负责人:Anjaparavanda P Naren
-
依托单位:
Administrative Core
-
批准号:10017685
-
项目类别:
-
资助金额:$19.95万
-
财政年份:2018
-
负责人:Anjaparavanda P Naren
-
依托单位:
Personalized Cystic Fibrosis Therapy and Research Center
-
批准号:10672704
-
项目类别:
-
资助金额:$21.85万
-
财政年份:2018
-
负责人:Anjaparavanda P Naren
-
依托单位:
Personalized Model System Core
-
批准号:10477252
-
项目类别:
-
资助金额:$22.61万
-
财政年份:2018
-
负责人:Anjaparavanda P Naren
-
依托单位:
Personalized Model System Core
-
批准号:10017687
-
项目类别:
-
资助金额:$22.69万
-
财政年份:2018
-
负责人:Anjaparavanda P Naren
-
依托单位:
Human Enteroids, Colonoids, and iPSC derived HIO's to study CFTR-relatedDisorders
-
批准号:9551790
-
项目类别:
-
资助金额:$10.24万
-
财政年份:2017
-
负责人:Anjaparavanda P Naren
-
依托单位:
LPA2 receptor-containing complexes in regulating secretory diarrhea
-
批准号:8698411
-
项目类别:
-
资助金额:$30.54万
-
财政年份:2011
-
负责人:Anjaparavanda P Naren
-
依托单位:
LPA2 receptor-containing complexes in regulating secretory diarrhea
-
批准号:8755868
-
项目类别:
-
资助金额:$28.72万
-
财政年份:2011
-
负责人:Anjaparavanda P Naren
-
依托单位:
LPA2 receptor-containing complexes in regulating secretory diarrhea
-
批准号:9284460
-
项目类别:
-
资助金额:$35.1万
-
财政年份:2011
-
负责人:Anjaparavanda P Naren
-
依托单位:
LPA2 receptor-containing complexes in regulating secretory diarrhea
-
批准号:8500254
-
项目类别:
-
资助金额:$0.72万
-
财政年份:2011
-
负责人:Anjaparavanda P Naren
-
依托单位:
LPA2 receptor-containing complexes in regulating secretory diarrhea
-
批准号:8192003
-
项目类别:
-
资助金额:$33.64万
-
财政年份:2011
-
负责人:Anjaparavanda P Naren
-
依托单位:
LPA2 receptor-containing complexes in regulating secretory diarrhea
-
批准号:8300093
-
项目类别:
-
资助金额:$29.36万
-
财政年份:2011
-
负责人:Anjaparavanda P Naren
-
依托单位:
Inhibition of an apical cAMP transporter (MRP4) in the gut induces diarrhea
-
批准号:8207256
-
项目类别:
-
资助金额:$31.63万
-
财政年份:2009
-
负责人:Anjaparavanda P Naren
-
依托单位:
Inhibition of an apical cAMP transporter (MRP4) in the gut induces diarrhea
-
批准号:7753861
-
项目类别:
-
资助金额:$36.24万
-
财政年份:2009
-
负责人:Anjaparavanda P Naren
-
依托单位:
Inhibition of an apical cAMP transporter (MRP4) in the gut induces diarrhea
-
批准号:7898171
-
项目类别:
-
资助金额:$7.18万
-
财政年份:2009
-
负责人:Anjaparavanda P Naren
-
依托单位:
海外基金